Medical News

RSS

Abnormal levels of circulating auto-antibodies found in blood of COPD patients

Moderate to severe chronic obstructive pulmonary disease (COPD) may be an auto-immunity problem, according to researchers in Spain, who studied the presence of auto-antibodies in patients with COPD and compared them to levels of control subjects. They found that a significant number of patients with COPD had significant levels of auto-antibodies circulating in their blood, about 5 to 10 times the level in controls.

20 Nov 2010

Scientist suggests functional amino acids play a critical role in human health

Functional amino acids play a critical role in the development of both animals and humans, according to a Texas AgriLife Research scientist.

20 Nov 2010

MEDSEEK clients awarded Strategic Communications eHealthcare Leadership Awards

MEDSEEK, the leading provider of enterprise eHealth solutions that give patients, clinicians and administrative staff an optimal 360-degree online experience, announced today that eight of its healthcare organization clients were awarded a total of 14 honors in the Strategic Communications eHealthcare Leadership Awards competition. The awards were presented at the 14th Annual Internet Healthcare Conference, held November 15-17, 2010, in Las Vegas, Nev.

20 Nov 2010

Insertable cardiac monitors may help physicians diagnose, treat patient with syncope: PICTURE trial

Medtronic, Inc. today announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.

20 Nov 2010

HealthPort enters agreement with CompuGroup to sell Solution Services Division

Today, HealthPort, a leading health information technology provider announced that it has entered into an agreement to sell its Solution Services Division based out of Columbia, SC to CompuGroup Medical AG.

20 Nov 2010

Gaiam declares early payment of annual dividend

Gaiam, Inc., a lifestyle media company, announced today that its Board of Directors declared the early payment of Gaiam's 2011 annual dividend of $0.15 per common share. Gaiam's Board determined that tax benefits potentially available to shareholders in 2010 justified the early payment of the 2011 dividend. The dividend, which will be recorded as a reduction of additional paid-in capital, will be payable on December 30, 2010 to common shareholders of record as of the close of business on December 15, 2010.

20 Nov 2010

Researchers develop social competence curriculum for autistic children

As the number of children diagnosed with autism spectrum disorders continues to increase, the one thing that won't change is the need for those children to develop social skills. Now, researchers at the University of Missouri are developing an effective social competence curriculum, with a virtual classroom component, that could help educators meet the demand of this growing population.

20 Nov 2010

MHD signs agreement with Riverside Medical for integrated healthcare delivery system

Exactly one year after the approval of the Environmental Impact Report and Specific Plan by the March Joint Powers Authority, March HealthCare Development, LLC (MHD) has signed an agreement with the Riverside Medical Clinic (RMC) that will be the foundation for a new integrated healthcare delivery system on the March LifeCare campus.

20 Nov 2010

Doctors provide tips to protect children from seasonal flu

Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are protected from influenza this flu season. The flu is an infection of the nose, throat and lungs caused by a variety of strains of influenza viruses. While the flu typically causes mild symptoms, it can be severe enough to cause hospitalization or even death. Flu most commonly occurs in the winter and early spring.

20 Nov 2010

High CRP and low protein albumin levels associated with increased risk of death after PEG-operations

The combination of high CRP and low levels of the protein albumin in the blood, is associated with an increased risk of death after a PEG-operation; implantation of a nutritional catheter into the stomach through the abdominal wall. This was shown in a new study from the Swedish medical university Karolinska Institutet, published in the scientific journal Gastrointestinal Endoscopy. Of the PEG patients in the study that showed both current indicators, 20 percent died within 30 days.

20 Nov 2010

Myrexis announces poster presentation on Azixa at Neuro-Oncology Scientific Meeting

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced a poster presentation of its lead product candidate Azixa (verubulin, MPC-6827) at the 2010 Society for Neuro-Oncology Scientific Meeting and Education Day in Montreal, Canada.

20 Nov 2010

New initiative to help improve oral health for North Carolina children

The North Carolina Head Start-State Collaboration Office and the American Academy of Pediatric Dentistry (AAPD), today announced the launch of the Head Start Dental Home Initiative to improve oral health for North Carolina children.

20 Nov 2010

Data from Rockwell Medical's Phase IIb study of SFP presented at ASN meeting

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that the Company will present new data at the American Society of Nephrology meeting being held in Denver, Colorado, on its late-stage investigational drug Soluble Ferric Pyrophosphate, which is being studied for the treatment of iron-deficiency anemia in ESRD patients.

20 Nov 2010

Allos Therapeutics to present FOLOTYN data for blood cancers at ASH Annual Meeting

Allos Therapeutics, Inc. today announced that five abstracts, describing FOLOTYN (pralatrexate injection) data across different types of blood cancers, were accepted in the program for this year's 52nd American Society of Hematology (ASH) Annual Meeting to be held December 4-7, 2010, in Orlando, Florida.

20 Nov 2010

MedSynergies receives gold-level award for website design

MedSynergies Inc., the leading provider of hospital-physician alignment solutions, received the gold-level award for achieving the best website design in the Corporate Business Improvement Site division of the 2010 eHealthcare Leadership Awards.

20 Nov 2010

PROTOX closes first tranche of investment by Warburg Pincus

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced it has closed the first tranche of the investment by Warburg Pincus. The investment was approved by 100% of the votes cast by shareholders at the recent special shareholders meeting.

20 Nov 2010

USC Norris designated Phase I Clinical Trial Center of Excellence

The USC Norris Comprehensive Cancer Center (USC Norris) has been designated a Phase I Clinical Trial Center of Excellence by global pharmaceutical company Bristol-Myers Squibb Company. The collaboration will bring a number of new phase I clinical trials to USC Norris, and will enable the cancer center's clinical and basic scientists to provide guidance in early phase drug development and trial design.

20 Nov 2010

Thorax Institute presents 18-year experience with SynCardia Artificial Heart at Acute Cardiac Care meeting

On Oct. 17, Dr. Jean Christian Roussel from the Thorax Institute at University Hospital of Nantes presented the center's 18-year experience with the SynCardia temporary Total Artificial Heart at the Acute Cardiac Care 2010 medical meeting in Copenhagen, Denmark.

20 Nov 2010

Evelyn Y. Davis gifts $100,000 to Swedish Medical Center

Swedish Medical Center announced today that it has received an unrestricted $100,000 gift from nationally known shareholder advocate Evelyn Y. Davis and the Evelyn Y. Davis Foundation. Since establishing her Foundation in 1989, Davis – who is from Washington, D.C. – has now made significant donations across the country to leading medical centers, nationally prominent universities, and various arts organizations.

20 Nov 2010

CombiMatrix receives Nasdaq noncompliance notice

CombiMatrix Corporation today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Market (as set forth in Nasdaq Listing Rule 5450(b)(1)(A)) because the Company's stockholders' equity is below The Nasdaq Global Market minimum stockholders' equity listing requirement of $10,000,000.

20 Nov 2010